In July, Qsymia, a combination of phentermine and topiramate, was approved for obese patients or those who are overweight with one weight-related condition such as high blood pressure, diabetes, or cholesterol. Phentermine is a stimulant that suppresses the appetite and topiramate is an anticonvulsant that makes people feel more satisfied after eating.
Women of child-bearing age are required to have a negative pregnancy test before starting the drug and monthly thereafter. Also, patients with recent or unstable heart disease or stroke aren’t good candidates for the drug because its effect on heart rates in those patients is not known.
Like all drug therapies, people respond differently to the same drug. At the Central Ohio Nutrition Center, each patient is individually evaluated medically to make sure that he/she is an appropriate candidate for the treatment. If interested in Qsymia, ask the Central Ohio Nutrition Center’s physician, about the medication. It may be useful also with maintenance after an initial weight loss on a very low calorie diet.
Patients who use Qsymia or any anti-obesity drug should be utilizing a comprehensive weight management program which involves dietary change, exercise, behavior modification in addition to the medical monitoring by the physician. The Central Ohio Nutrition Center has been involved with anti-obesity medications since 1993. The good news is that we now have another tool in the treatment of obesity!